Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXC0XI
|
||||
Drug Name |
1-{4-[4-((R)-8-Chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-piperazine-1-carbonyl]-piperidin-1-yl}-ethanone
|
||||
Synonyms |
CHEMBL354622
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C26H31ClN4O2
|
||||
Canonical SMILES |
CC(=O)N1CCC(CC1)C(=O)N2CCN(CC2)[C@@H]3c4ccc(Cl)cc4CCc5cccnc35
|
||||
InChI |
InChI=1S/C26H31ClN4O2/c1-18(32)29-11-8-20(9-12-29)26(33)31-15-13-30(14-16-31)25-23-7-6-22(27)17-21(23)5-4-19-3-2-10-28-24(19)25/h2-3,6-7,10,17,20,25H,4-5,8-9,11-16H2,1H3/t25-/m1/s1
|
||||
InChIKey |
CHCGFVNHRVYCBU-RUZDIDTESA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.